EIF4G2 and neoplasm: As presented in Figures 1(c)–1(g), we found that based on the analysis of sample types, patients' gender, nodal metastasis status, individual cancer stages, and tumor grades, the expression of EIF4G2 in GC tissues was significantly higher than in normal tissues.